Behavioral Neurobiology of Schizophrenia and Its Treatment
Neal R. Swerdlow
Springer Science & Business Media, Aug 19, 2010 - Medical - 666 pages
This book describes the state-of-the-art of treatment of schizophrenia and reflects its development in 22 chapters written by leading authorities in the field
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
abnormalities activity agonist animal models Arch Gen Psychiatry aripiprazole assessment associated atypical antipsychotics auditory behavioral Biol Psychiatry bipolar disorder Braff Brain Res calcineurin chronic Clin clinical clozapine cognitive deficits controls correlation cortical D2 receptors decreased deficits in schizophrenia differences DISC1 disease disorder DLPFC DNA methylation dopamine dose drug dysfunction effects endophenotypes evidence eye movements first-episode frontal GABA gene genetic Geyer glutamate gyrus haloperidol hippocampal human impaired increased lesions measures memory metabolic mice model of schizophrenia modulation negative symptoms neural neurocognitive neuroimaging neurons Neuropsychopharmacology Neurosci neurotransmitter nicotine NMDA receptor olanzapine patients with schizophrenia phrenia potential prefrontal cortex prenatal prepulse inhibition processing prodromal protein Psychiatry Psychopharmacology psychosis psychotic quetiapine rats regions response risk risperidone saccades schizo Schizophr Bull Schizophr Res schizophrenia patients signaling significant smooth pursuit social specific stimulus striatal subjects Swerdlow target task temporal thalamus treatment volume Weinberger DR ziprasidone